Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $10.53 USD
Change Today +0.28 / 2.73%
Volume 119.8K
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew D. Zelenetz M.D., Ph.D.

Member of Scientific Advisory Board, Cancer Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Andrew D. Zelenetz, M.D., Ph.D serves as Head of the Molecular Hemo-oncology Laboratory in the Department of Medicine of MSKCC. Dr. Zelenetz joined MSKCC in 1991. Dr. Zelenetz serves as Vice Chairman of Medical Informatics, Dept of Medicine, Memorial Sloan-Kettering Cancer Center and Associate Professor of Medicine at Weill Medical College, Cornell University. He served as Chief of Lymphoma Service, Division at Hematology/Oncology at MSKCC from 1994 to 2013. Dr. ...

Read Full Background

Corporate Headquarters*

201 Route 17 North
Rutherford, New Jersey 07070

United States

Phone: 201-528-9200
Fax: 201-528-9201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Harvard University
MD
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGIX:US $10.53 USD +0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$800.0K
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CANCER GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.